Publication |
Nobuyuki Miyasaka, M.D., Ph.D. 宮坂信之 |
1. |
Miyasaka N Clinical investigation in highly diseaseaffected rheumatologic arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study. Mod. Rheumatol. 18(3):252-262, 2008 |
2. |
◎Sekine C, Sugihara T, Miyake S, Hirai H, Yoshida M, Miyasaka N, Kohsaka H Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J. Immunol. 180:1954-1961, 2008 |
3. |
◎Nakamoto T, Seo S, Sakai R, Kato T, Kutsuna H, Kurokawa M, Noda M, Miyasaka N, Kitagawa S Expression and tyrosine phosphorylation of Crk associated substrate lymphocyte type(Cas-L) protein in human neutrophils. J. Cell. Biochem. 105:121-128, 2008 |
4. |
Saito E, Koike T, Hashimoto H, Miyasaka N, Ikeda Y, Hara M, Yamada H, Yoshida T, Harigai M, Ichikawa Y Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis. Additional members of the GB-0998 Study Group Mod. Rheumatol. 18:34-44, 2008 |
5. |
◎Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. J. Cellular Phys. 216:47-53, 2008 |
6. |
Mizoguchi F, Nanki T, Takada K, Miyasaka N Recurrent pulmonary embolism due to intracardiac thrombi in systemic sclerosis. Clin. Exp. Rheum. 26:157, 2008 |
7. |
◎Tazaki T, Miyazaki K, Hiyama E, Nakamoto T, Sakai R, Yamasaki T, Honda Z, Noda M, Miyasaka N, Sueda T, Honda H Functional analysis of Src homology 3-encoding exon( exon 2) of p130Cas in primary fibroblasts derived from exon 2-specific knockout mice. Genes to Cells 13:145-157, 2008 |
8. |
Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, Miyasaka N Excessive production of IFN- γ in patients with Systemic Lupus Erythematosus and its contribution to induction of B lymphocyte stimulator / B cell-activating factor / TNF ligand superfamily-13B1. J. Immunol. 181(3):2211-2219, 2008 |
9. |
Mizoguchi F, Nanki T, Miyasaka N Pneumatosis cystoides intestinalis following lupus enteritis and peritonitis. Intern. Med. 47(13):1267-1271, 2008 |
10. |
Mizoguchi F, Nakamura S, Iwai H, Kubota T, Miyasaka N Varicella-Zoster virus hepatitis in polymyositis. Mod. Rheumatol. 18(3):301-305, 2008 |
11. |
Miyasaka N Adalimumab for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology in press |
12. |
Watanabe K, Nanki T, Sugihara T, Miyasaka N A case of polyarteritis nodosa with periurethral aseptic abscesses and testicular lesions. Clin. Exp. Rheumatol. 26:1113-1115, 2008 |
13. |
Nii T, Kubota T, Nanki T, Komano Y, Harigai M, Kohsaka H, Hirose W, Nagasaka K, Sakurai T, Miyasaka N Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers. Mod. Rheumatol. LETTER in press |
14. |
◎ Nonomura Y, Mizoguchi F, Suzuki A, Nanki T, Kato H, Miyasaka N, Kohsaka H Hypoxia-induced abrogation of contact-dependent inhibition of rheumatoid arthritis synovial fibroblast proliferation. J. Rheumatol. in press |
15. |
Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, Kishimoto T Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate( SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod. Rheumatol. in press |
16. |
Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H Intervention of triggering receptor expressed on myeloid cells-1 signaling for modest immunosuppression to treat autoimmune arthritis. Arthritis & Rheumatism. in press |
17. |
Okiyama N, Kohsaka H, Ueda N, Satoh T, Katayama I, Nishioka K, and Yokozeki H Seborrhic area erythema as a common skin manifestation in Japanese patients with dermatomyositis. Dermatology 217(4):374-377, 2008 |
18. |
Matsudaira T, Tsuzuki S, Wada A, Suwa A, Kohsaka H, Tomida M, and Ito Y Automated microfluidic assay system for autoantibodies causing autoimmune diseases using a photoimmobilized autoantigen microarray. Biotechnology Progress 24(6):1384-1392, 2008 |
19. |
Hirose W, Nishikawa K, Hirose M, Nanki T, Sugimoto H Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging. Mod. Rheumatol. in press |
20. |
Komano Y, Harigai M, Koike R, Sugiyama H, Ogawa J, Saito K, Sekiguchi N, Inoo M, Onishi I, Ohashi H, Amamoto F, Miyata M, Ohtsubo H, Hiramatsu K, Iwamoto M, Minota S, Matsuoka N, Kageyama G, Imaizumi K, Tokuda H, Okochi Y, Kudo K, Tanaka Y, Takeuchi T, Miyasaka N Pneumocystis pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. Arthritis Care & Res. in press |
21. |
Kishi J, Nanki T, Watanabe K, Takamura A, Miyasaka N. A case of systemic lupus erythematosus complicated with rituximab-induced interstitial pneumonia. Rheumatology in press |